Floatz logo

BLOOD-COAGULATION FACTOR IX (148-THREONINE) (SYNTHETIC HUMAN ISOFORM IB1001)

Ataxia Telangiectasia

IntraBio Incprotein_peptidePhase 2Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Ataxia Telangiectasia cohort.

Asset / SponsorPhaseRating
17-beta-estradiol
Johann Wolfgang Goethe University Hospital
Phase 4BB
ARG
Johann Wolfgang Goethe University Hospital
Phase 4BB
ROPIVACAINE
Quince Therapeutics S.p.A.
Phase 3BB
Genotropin
Johann Wolfgang Goethe University Hospital
Phase 4BB
DEXAMETHASONE
Quince Therapeutics S.p.A.
Phase 3B

View all 13 →

Same molecule, other indications

BLOOD-COAGULATION FACTOR IX (148-THREONINE) (SYNTHETIC HUMAN ISOFORM IB1001) is also rated in:

hemophilia BDormant
B
Indicative ·
56 / 100
View asset →
Niemann-Pick disease type CDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →